Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeffrey Kaine
Evaluation of Abatacept Administered Subcutaneously in Adults With Active Rheumatoid Arthritis: Impact of Withdrawal and Reintroduction on Immunogenicity, Efficacy and Safety (Phase Iiib ALLOW Study)
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Related publications
The Efficacy and Safety of Abatacept in Rheumatoid Arthritis
Therapeutic Advances in Musculoskeletal Disease
Rheumatology
Orthopedics
Sports Medicine
Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/Ii Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Efficacy, Safety, and Tolerability of Abatacept in the Management of Rheumatoid Arthritis
Open Access Rheumatology: Research and Reviews
Rheumatology
Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis
Advances in Clinical and Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients With Rheumatoid Arthritis Receiving Background Methotrexate: A 5-Year Extended Phase IIB Study
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Efficacy and Safety of Tofacitinib as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis: A 12-Week, Randomized, Phase 2 Study
Modern Rheumatology
Medicine
Rheumatology
Effects of Abatacept on Monocytes in Patients With Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted With MF59 Administered to Healthy Adults
Vaccine
Molecular Medicine
Public Health
Veterinary
Microbiology
Environmental
Immunology
Infectious Diseases
Occupational Health